Allogeneic mesenchymal stem cell as induction therapy to prevent both delayed graft function and acute rejection in deceased donor renal transplantation: study protocol for a randomized controlled trial

Allogeneic mesenchymal stem cell as induction therapy to prevent both delayed graft function and acute rejection in deceased donor renal transplantation: study protocol for a randomized controlled trial

Abstract Background Using kidneys from deceased donors is an available strategy to meet the growing need of grafts. However, higher incidences of delayed graft function (DGF) and acute rejection exert adverse effects on graft outcomes. Since ischemia-reperfusion injury (IRI) and ongoing process of i...

Full description

Bibliographic Details
Main Authors: Qipeng Sun, Liangqing Hong, Zhengyu Huang, Ning Na, Xuefeng Hua, Yanwen Peng, Ming Zhao, Ronghua Cao, Qiquan Sun
Format: Article
Language:English
Published: BMC 2017-11-01
Series:Trials
Subjects:
Mesenchymal stem cell
Renal transplantation
Delayed graft function
Acute rejection
Online Access:http://link.springer.com/article/10.1186/s13063-017-2291-y

Internet

http://link.springer.com/article/10.1186/s13063-017-2291-y

Similar Items